Serina Therapeutics (SER) Minority Interest (2017 - 2025)

Historic Minority Interest for Serina Therapeutics (SER) over the last 9 years, with Q3 2025 value amounting to -$166000.0.

  • Serina Therapeutics' Minority Interest fell 20740.74% to -$166000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$166000.0, marking a year-over-year decrease of 20740.74%. This contributed to the annual value of -$133000.0 for FY2024, which is 10036.53% down from last year.
  • According to the latest figures from Q3 2025, Serina Therapeutics' Minority Interest is -$166000.0, which was down 20740.74% from -$156000.0 recorded in Q2 2025.
  • In the past 5 years, Serina Therapeutics' Minority Interest ranged from a high of $36.4 million in Q4 2023 and a low of -$166000.0 during Q3 2025
  • Over the past 5 years, Serina Therapeutics' median Minority Interest value was -$49500.0 (recorded in 2022), while the average stood at $1.9 million.
  • Per our database at Business Quant, Serina Therapeutics' Minority Interest surged by 3544368.93% in 2023 and then plummeted by 42000.0% in 2025.
  • Serina Therapeutics' Minority Interest (Quarter) stood at -$43000.0 in 2021, then crashed by 139.53% to -$103000.0 in 2022, then soared by 35443.69% to $36.4 million in 2023, then tumbled by 100.37% to -$133000.0 in 2024, then decreased by 24.81% to -$166000.0 in 2025.
  • Its Minority Interest stands at -$166000.0 for Q3 2025, versus -$156000.0 for Q2 2025 and -$142000.0 for Q1 2025.